Simple fluid test may predict healthy embryos in IVF

NCT ID NCT05837325

Recruiting now Knowledge-focused Sponsor: ART Fertility Clinics LLC Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether levels of Anti-Müllerian hormone (AMH) in the fluid around a woman's eggs can predict if an embryo has the right number of chromosomes. Researchers will collect fluid from one follicle in each ovary during egg retrieval in 300 women undergoing IVF. They will then compare AMH levels to the genetic health of the resulting embryos. If a link is found, it might offer a less invasive way to choose the best embryos for transfer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors choose the healthiest embryos for IVF without needing genetic testing, potentially improving pregnancy success rates.
What could go wrong: This is an early observational study, not a treatment trial. The link between AMH and embryo genetics may not be strong enough to change practice, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFERTILITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

female infertility infertility disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFERTILITY INFERTILITY, FEMALE

Contacts and locations

Locations

ART Fertility Clinics LLC
RECRUITING

Abu Dhabi, Abu Dhabi Emirate, 60202, United Arab Emirates

More trials for these conditions

Other studies related to the condition(s) this trial covers.